{"id":"meptazinol","rwe":[],"tags":[{"label":"meptazinol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Mu-type opioid receptor","category":"target"},{"label":"OPRM1","category":"gene"},{"label":"SLC22A1","category":"gene"},{"label":"N02AX05","category":"atc"},{"label":"Active","category":"status"},{"label":"Moderate pain","category":"indication"},{"label":"Analgesics","category":"pharmacology"},{"label":"Analgesics, Opioid","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Central Nervous System Depressants","category":"pharmacology"},{"label":"Narcotic Antagonists","category":"pharmacology"},{"label":"Narcotics","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sensory System Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=MEPTAZINOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:33:53.164390+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:33:58.482615+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MEPTAZINOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:33:58.813419+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1477274/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:33:59.540060+00:00"}},"allNames":"meptamizol","offLabel":[],"synonyms":["meptazinol hydrochloride","meptazinol","meptamizol","(+/-)-Meptazinol","meptazinol HCl","WY22811","WY-22811"],"timeline":[{"date":"1983-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1983-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Meptamizol","ecosystem":[{"indication":"Moderate pain","otherDrugs":[{"name":"oliceridine","slug":"oliceridine","company":"Trevena Inc"}],"globalPrevalence":null}],"mechanism":{"target":"Mu-type opioid receptor","targets":[{"gene":"OPRM1","source":"DrugCentral","target":"Mu-type opioid receptor","protein":"Mu-type opioid receptor"},{"gene":"SLC22A1","source":"DrugCentral","target":"Solute carrier family 22 member 1","protein":"Solute carrier family 22 member 1"}],"modality":"Small Molecule","drugClass":"meptazinol","explanation":"","oneSentence":"","technicalDetail":"Meptazinol acts as a mu-opioid receptor agonist, activating the receptor and initiating a cascade of downstream effects that ultimately lead to analgesia."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1706","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MEPTAZINOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:01:49.656808","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:34:01.269821+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"tramadol","drugSlug":"tramadol","fdaApproval":"1995-03-03","patentExpiry":"Sep 1, 2040","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"dezocine","drugSlug":"dezocine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"tapentadol","drugSlug":"tapentadol","fdaApproval":"2008-11-20","patentExpiry":"Sep 22, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"oliceridine","drugSlug":"oliceridine","fdaApproval":"2020-08-07","patentExpiry":"Mar 23, 2032","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"naloxone","drugSlug":"naloxone","fdaApproval":"1971-04-13","patentExpiry":"Oct 30, 2028","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"meptazinol","indications":{"approved":[{"name":"Moderate pain","source":"DrugCentral","snomedId":50415004,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"tramadol","brandName":"tramadol","genericName":"tramadol","approvalYear":"1995","relationship":"same-class"},{"drugId":"dezocine","brandName":"dezocine","genericName":"dezocine","approvalYear":"","relationship":"same-class"},{"drugId":"tapentadol","brandName":"tapentadol","genericName":"tapentadol","approvalYear":"2008","relationship":"same-class"},{"drugId":"oliceridine","brandName":"oliceridine","genericName":"oliceridine","approvalYear":"2020","relationship":"same-class"},{"drugId":"naloxone","brandName":"naloxone","genericName":"naloxone","approvalYear":"1971","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004001","UNII":"18Y7S5JKZD","CHEBI":"CHEBI:91484","INN_ID":"3605","RXNORM":"11347","UMLSCUI":"C0025387","chemblId":"CHEMBL1477274","ChEMBL_ID":"CHEMBL314437","KEGG_DRUG":"D04924","DRUGBANK_ID":"DB13478","PUBCHEM_CID":"41049","SNOMEDCT_US":"354055003","IUPHAR_LIGAND_ID":"9083","SECONDARY_CAS_RN":"59263-76-2","MESH_DESCRIPTOR_UI":"D008621"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.7 hours","clearance":"28.0 mL/min/kg","bioavailability":"9%","fractionUnbound":"0.73%","volumeOfDistribution":"3.3 L/kg"},"publicationCount":232,"therapeuticAreas":["Pain"],"atcClassification":{"source":"DrugCentral","atcCode":"N02AX05","allCodes":["N02AX05"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1983-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:34:01.269821+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}